Clinical trials recruiting for Urogenital Neoplasms
4
Recruiting trials
14
US states with sites
8
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 2Phase 2 2Phase 4 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 18F-Fluciclovine PET/CT Scan | 1 |
| Docetaxel (Taxotere) | 1 |
| Irinotecan (Camptosar) | 1 |
| Lutetium (177Lu) rhPSMA-10.1 Injection | 1 |
| STAR0602 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Florida | 2 |
| Maryland | 2 |
| Georgia | 1 |
| Kansas | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| Nebraska | 1 |
| New York | 1 |
| Ohio | 1 |
| Tennessee | 1 |
| Texas | 1 |
Top cities
Bethesda, Maryland 2Miami, Florida 2Atlanta, Georgia 1Boston, Massachusetts 1Celebration, Florida 1Columbus, Ohio 1Detroit, Michigan 1Houston, Texas 1Kansas City, Kansas 1Los Angeles, California 1
Self-screener
Recruiting trials
- 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
- A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Related conditions
Trials recruiting for Urogenital Neoplasms often also study these conditions. Each links to its own recruiting-trial list.
Prostate cancer 1234Prostatic Neoplasms 36Prostatic Diseases 3Neoplasms by Site 11Urothelial Cancer 6Prostatic Neoplasms, Castration-Resistant 13Non-small cell lung cancer 507Metastatic Prostate Cancer 45Metastatic Castration-resistant Prostate Cancer 67Melanoma 487
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Urogenital Neoplasms trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.